Terms: = Pancreatic cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Clinical Outcome
11 results:
1. Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or muc1 peptide-loaded dendritic cell vaccination and a standard chemotherapy.
Ota S; Miyashita M; Yamagishi Y; Ogasawara M
Hum Vaccin Immunother; 2021 Dec; 17(12):5563-5572. PubMed ID: 34919493
[TBL] [Abstract] [Full Text] [Related]
2. Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial.
Ogasawara M; Miyashita M; Yamagishi Y; Ota S
Ther Apher Dial; 2021 Aug; 25(4):415-424. PubMed ID: 33886156
[TBL] [Abstract] [Full Text] [Related]
3. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic pancreatic Adenocarcinoma.
Dotan E; Alpaugh RK; Ruth K; Negin BP; Denlinger CS; Hall MJ; Astsaturov I; McAleer C; Fittipaldi P; Thrash-Bingham C; Meropol NJ; Cohen SJ
Pancreas; 2016 Sep; 45(8):1131-5. PubMed ID: 26967453
[TBL] [Abstract] [Full Text] [Related]
5. Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.
Nishikawa H; Osaki Y
Mediators Inflamm; 2015; 2015():872152. PubMed ID: 26494949
[TBL] [Abstract] [Full Text] [Related]
6. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Distler M; Kersting S; Niedergethmann M; Aust DE; Franz M; Rückert F; Ehehalt F; Pilarsky C; Post S; Saeger HD; Grützmann R
Ann Surg; 2013 Aug; 258(2):324-30. PubMed ID: 23532107
[TBL] [Abstract] [Full Text] [Related]
7. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
[TBL] [Abstract] [Full Text] [Related]
8. Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.
Jhavar S; Brewer D; Edwards S; Kote-Jarai Z; Attard G; Clark J; Flohr P; Christmas T; Thompson A; Parker M; Shepherd C; Stenman UH; Marchbank T; Playford RJ; Woodhouse C; Ogden C; Fisher C; Kovacs G; Corbishley C; Jameson C; Norman A; De-Bono J; Bjartell A; Eeles R; Cooper CS
BJU Int; 2009 May; 103(9):1256-69. PubMed ID: 19040532
[TBL] [Abstract] [Full Text] [Related]
9. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract] [Full Text] [Related]
10. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
[TBL] [Abstract] [Full Text] [Related]
11. Enhancement of metastatic properties of pancreatic cancer cells by muc1 gene encoding an anti-adhesion molecule.
Satoh S; Hinoda Y; Hayashi T; Burdick MD; Imai K; Hollingsworth MA
Int J Cancer; 2000 Nov; 88(4):507-18. PubMed ID: 11058865
[TBL] [Abstract] [Full Text] [Related]